Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diverticular Disease of the Colon

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Immunodeficiency Diseases

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...

Inflammatory Bowel Disease II: Crohn's Disease

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Intravenous Steroids Do Not Improve Short-Term Outcomes of Patients With Crohn's Disease Presenting With an Acute Small Bowel Obstruction.

Crohn's & colitis 360·2025

Same author

Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting.

The lancet. Gastroenterology & hepatology·2023

Same author

Long-Term Outcomes of the Excluded Rectum in Crohn's Disease: A Multicenter International Study.

Inflammatory bowel diseases·2022

Same author

IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2022

Same author

Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases.

The lancet. Gastroenterology & hepatology·2022

Same author

Diversion proctocolitis and the problem of the forgotten rectum in inflammatory bowel diseases: A systematic review.

United European gastroenterology journal·2021

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Diverticulitis in immunosuppressed patients.

David B Sachar¹,

¹Division of Gastroenterology, Mount Sinai School of Medicine, New York, NY, USA. david.sachar@mountsinai.org

Journal of Clinical Gastroenterology

|October 22, 2008

Summary

This summary is machine-generated.

Diverticulitis diagnosis in immunosuppressed patients, including transplant and AIDS patients, should follow standard protocols. Immunocompromised individuals face higher postoperative infection risks correlated with immune deficiency severity.

More Related Videos

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Related Experiment Videos

Last Updated: Jun 28, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Murine Distal Colostomy, A Novel Model of Diversion Colitis in C57BL/6 Mice

Published on: July 12, 2018

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

Area of Science:

Gastroenterology
Immunology
Surgical Oncology

Background:

Abdominal pain is a common symptom with a broad differential diagnosis.
Immunosuppression, seen in transplant recipients and patients with Acquired Immunodeficiency Syndrome (AIDS), alters disease presentation and complicates management.
Diverticulitis is a frequent cause of abdominal pain, particularly in older populations.

Purpose of the Study:

To evaluate if the diagnostic approach to diverticulitis in immunosuppressed patients differs from that in immunocompetent individuals.
To assess the impact of immunosuppression on the clinical presentation and diagnosis of diverticulitis.
To highlight the implications of immune deficiency on surgical outcomes in patients with diverticulitis.

Main Methods:

Retrospective chart review of patients presenting with abdominal pain.
Comparison of diagnostic workups and clinical findings between immunosuppressed (transplant, AIDS) and immunocompetent patient groups.
Analysis of postoperative infectious complication rates in relation to the degree of immune suppression.

Main Results:

The diagnostic approach for diverticulitis in immunosuppressed patients should not differ based on their immune status compared to age- and sex-matched controls with similar presentations.
Immunosuppressed patients exhibit similar clinical presentations of diverticulitis as immunocompetent patients.
A direct correlation exists between the degree of immune deficiency and the increased risk of postoperative infectious complications.

Conclusions:

The diagnostic strategy for diverticulitis remains consistent across patient populations, irrespective of immunosuppression.
Physicians should maintain a high index of suspicion for diverticulitis in immunosuppressed patients presenting with abdominal pain.
Managing immunosuppressed patients requires careful consideration of heightened postoperative infectious risks, necessitating proactive preventive measures.